In the first study, a comparison of serum samples from normal healthy donors and pancreatic cancer donors revealed a positive correlation between serum IL-8 levels and catabolic conditions of cancer cachexia status, weight loss, and sarcopenia [89]. This evidence concerns the gene CXCL8 and pancreatic neoplasm.